Literature DB >> 17383811

Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Varant Kupelian1, Carol L Link, John B McKinlay.   

Abstract

INTRODUCTION: Although previous studies report an association between erectile dysfunction (ED) and smoking, few have examined the impact of passive smoke exposure on ED. This analysis examines the association of active and passive smoking and ED and investigates a dose-response effect of smoking.
METHODS: The Boston Area Community Heath (BACH) survey is a study of urologic symptoms in a racially and ethnically diverse population. BACH used a multistage stratified random sample to recruit 2301 men, aged 30-79 yr, from the city of Boston. ED was assessed using the five-item International Index of Erectile Function. Smoking and passive smoking were assessed by self-report. Analyses adjusted for sociodemographic and lifestyle factors and important chronic illnesses.
RESULTS: An association between smoking and ED was observed with a significant trend in increased risk of ED with cumulative pack-years of smoking (adjusted odds ratio [OR]=1.68; 95% confidence interval [CI], 1.03, 2.30 for > or =20 pack-years). Compared to never smokers not exposed to passive smoking, men who never smoked but were exposed to passive smoking had a moderate, statistically nonsignificant, increase in risk of ED (adjusted OR=1.33; 95%CI: 0.69, 2.55) comparable to the OR observed for a cumulative exposure of 10-19 pack-years of active smoking (adjusted OR=1.25; 95%CI, 0.68, 2.30).
CONCLUSIONS: Results indicate a dose-response association between smoking and ED with a statistically significant effect observed with > or =20 pack-years of exposure. Passive smoking is associated with a small, statistically nonsignificant increase in risk of ED comparable to approximately 10-19 pack-years of active smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383811      PMCID: PMC2139983          DOI: 10.1016/j.eururo.2007.03.015

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  30 in total

1.  Heart disease risk factors predict erectile dysfunction 25 years later (the Rancho Bernardo Study).

Authors:  Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2005-07-27       Impact factor: 2.778

2.  Predictors and prevalence of erectile dysfunction in a racially diverse population.

Authors:  Christopher S Saigal; Hunter Wessells; Jennifer Pace; Matt Schonlau; Timothy J Wilt
Journal:  Arch Intern Med       Date:  2006-01-23

3.  Smoking as a risk factor for erectile dysfunction: data from the Andrology Prevention Weeks 2001-2002 a study of the Italian Society of Andrology (s.I.a.).

Authors:  Edoardo Austoni; Vincenzo Mirone; Fabio Parazzini; Ciro Basile Fasolo; Paolo Turchi; Edoardo S Pescatori; Elena Ricci; Vincenzo Gentile
Journal:  Eur Urol       Date:  2005-03-16       Impact factor: 20.096

4.  Passive smoking impairs endothelium-dependent relaxation of isolated rabbit arteries.

Authors:  J Török; A Gvozdjáková; J Kucharská; I Balazovjech; S Kyselá; F Simko; J Gvozdják
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

5.  A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly.

Authors:  C L Turvey; R B Wallace; R Herzog
Journal:  Int Psychogeriatr       Date:  1999-06       Impact factor: 3.878

6.  Smoking causes erectile dysfunction through vascular disease.

Authors:  Rahman Shiri; Jukka Häkkinen; Juha Koskimäki; Teuvo L J Tammela; Anssi Auvinen; Matti Hakama
Journal:  Urology       Date:  2006-12-04       Impact factor: 2.649

7.  The Physical Activity Scale for the Elderly (PASE): development and evaluation.

Authors:  R A Washburn; K W Smith; A M Jette; C A Janney
Journal:  J Clin Epidemiol       Date:  1993-02       Impact factor: 6.437

8.  Smoking and other lifestyle factors in relation to erectile dysfunction.

Authors:  Jane Y Polsky; Kristan J Aronson; Jeremy P W Heaton; Michael A Adams
Journal:  BJU Int       Date:  2005-12       Impact factor: 5.588

9.  Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat.

Authors:  Y Xie; H Garban; C Ng; J Rajfer; N F Gonzalez-Cadavid
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

10.  Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction.

Authors:  M Wei; C A Macera; D R Davis; C A Hornung; H R Nankin; S N Blair
Journal:  Am J Epidemiol       Date:  1994-11-15       Impact factor: 4.897

View more
  21 in total

1.  Is hyperlipidemia or its treatment associated with erectile dysfunction?: Results from the Boston Area Community Health (BACH) Survey.

Authors:  Susan A Hall; Varant Kupelian; Raymond C Rosen; Thomas G Travison; Carol L Link; Martin M Miner; Peter Ganz; John B McKinlay
Journal:  J Sex Med       Date:  2009-02-09       Impact factor: 3.802

Review 2.  What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng.

Authors:  Mark A Moyad; Kwangsung Park
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

3.  Cohort profile: the Boston Area Community Health (BACH) survey.

Authors:  Rebecca S Piccolo; Andre B Araujo; Neil Pearce; John B McKinlay
Journal:  Int J Epidemiol       Date:  2012-12-05       Impact factor: 7.196

4.  Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Andre B Araujo; Gretchen R Chiu; Raymond C Rosen; John B McKinlay
Journal:  Prev Med       Date:  2009-11-24       Impact factor: 4.018

5.  Risk factors for incident erectile dysfunction among community-dwelling men.

Authors:  Susan A Hall; Rebecca Shackelton; Raymond C Rosen; Andre B Araujo
Journal:  J Sex Med       Date:  2009-11-19       Impact factor: 3.802

6.  Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction.

Authors:  Trinity J Bivalacqua; Thomas E Sussan; Melina A Gebska; Travis D Strong; Dan E Berkowitz; Shyam Biswal; Arthur L Burnett; Hunter C Champion
Journal:  J Urol       Date:  2008-12-17       Impact factor: 7.450

Review 7.  Erectile dysfunction.

Authors:  Faysal A Yafi; Lawrence Jenkins; Maarten Albersen; Giovanni Corona; Andrea M Isidori; Shari Goldfarb; Mario Maggi; Christian J Nelson; Sharon Parish; Andrea Salonia; Ronny Tan; John P Mulhall; Wayne J G Hellstrom
Journal:  Nat Rev Dis Primers       Date:  2016-02-04       Impact factor: 52.329

Review 8.  Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation.

Authors:  Rita C Tostes; Fernando S Carneiro; Anthony J Lee; Fernanda R C Giachini; Romulo Leite; Yoichi Osawa; R Clinton Webb
Journal:  J Sex Med       Date:  2008-03-04       Impact factor: 3.802

Review 9.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 10.  Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

Authors:  F Giuliano; G Jackson; F Montorsi; A Martin-Morales; P Raillard
Journal:  Int J Clin Pract       Date:  2009-11-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.